Mackenzie Financial Corp lifted its position in Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 406.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 60,595 shares of the company's stock after buying an additional 48,621 shares during the period. Mackenzie Financial Corp owned approximately 0.12% of Nu Skin Enterprises worth $418,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Susquehanna International Group LLP increased its holdings in shares of Nu Skin Enterprises by 191.9% in the fourth quarter. Susquehanna International Group LLP now owns 702,127 shares of the company's stock valued at $4,838,000 after purchasing an additional 461,608 shares during the period. Two Sigma Advisers LP boosted its position in Nu Skin Enterprises by 61.2% in the fourth quarter. Two Sigma Advisers LP now owns 944,000 shares of the company's stock valued at $6,504,000 after buying an additional 358,400 shares during the last quarter. D. E. Shaw & Co. Inc. increased its holdings in Nu Skin Enterprises by 15.5% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 2,251,352 shares of the company's stock worth $15,512,000 after buying an additional 301,295 shares during the period. JPMorgan Chase & Co. raised its position in Nu Skin Enterprises by 74.9% during the 4th quarter. JPMorgan Chase & Co. now owns 405,667 shares of the company's stock worth $2,795,000 after buying an additional 173,710 shares during the last quarter. Finally, Two Sigma Investments LP lifted its stake in Nu Skin Enterprises by 24.2% during the 4th quarter. Two Sigma Investments LP now owns 700,500 shares of the company's stock valued at $4,826,000 after acquiring an additional 136,624 shares during the period. Hedge funds and other institutional investors own 82.84% of the company's stock.
Insider Buying and Selling
In other news, Director Edwina D. Woodbury sold 4,532 shares of the business's stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $8.44, for a total transaction of $38,250.08. Following the completion of the sale, the director now owns 42,947 shares of the company's stock, valued at $362,472.68. The trade was a 9.55% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Steven Keith Hatchett bought 6,500 shares of Nu Skin Enterprises stock in a transaction on Wednesday, May 28th. The shares were purchased at an average cost of $7.54 per share, with a total value of $49,010.00. Following the acquisition, the insider now directly owns 162,065 shares of the company's stock, valued at approximately $1,221,970.10. The trade was a 4.18% increase in their ownership of the stock. The disclosure for this purchase can be found here. 2.00% of the stock is currently owned by insiders.
Analyst Ratings Changes
Separately, Wall Street Zen upgraded shares of Nu Skin Enterprises from a "hold" rating to a "buy" rating in a research note on Monday, May 12th.
Read Our Latest Research Report on NUS
Nu Skin Enterprises Stock Performance
Shares of NYSE:NUS traded up $0.15 during midday trading on Friday, reaching $7.93. The company's stock had a trading volume of 308,712 shares, compared to its average volume of 836,213. The firm has a market capitalization of $391.85 million, a PE ratio of -2.69 and a beta of 0.98. Nu Skin Enterprises, Inc. has a twelve month low of $5.32 and a twelve month high of $13.70. The stock has a fifty day moving average of $6.70 and a 200 day moving average of $7.07. The company has a quick ratio of 1.17, a current ratio of 1.82 and a debt-to-equity ratio of 0.56.
Nu Skin Enterprises (NYSE:NUS - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $0.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.15 by $0.08. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. The firm had revenue of $364.49 million during the quarter, compared to analysts' expectations of $352.06 million. On average, equities analysts expect that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current fiscal year.
Nu Skin Enterprises Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 11th. Investors of record on Friday, May 30th will be paid a $0.06 dividend. This represents a $0.24 annualized dividend and a dividend yield of 3.03%. The ex-dividend date is Friday, May 30th. Nu Skin Enterprises's dividend payout ratio is currently -30.00%.
About Nu Skin Enterprises
(
Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Further Reading

Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.